Short interest in Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN) increased during the last reporting period, rising from 20.84K to 66.23K. This put 1.29% of the company's publicly available shares short.

Short interest for Sonnet BioTherapeutics gives investors a sense of the degree to which investors are betting on the decline of Sonnet BioTherapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 45.80K shares traded per day, it would take 1.45 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.